🩺 Hypertension Grading & Treatment Initiation
This tool grades office hypertension and, combined with cardiovascular risk, gives the timing of drug initiation and the blood-pressure target per the 2024 Chinese hypertension guideline.
Hypertension Grading & Treatment Initiation
Systolic BP (office) (mmHg)
Diastolic BP (office) (mmHg)
Cardiovascular risk stratification
Comorbid diabetes/CKD/coronary disease
Age ≥ 80 yr
When to use
Use to decide when to start antihypertensives — immediately for Grade 3 or high/very-high risk, after a lifestyle trial otherwise — and to set the BP target by age and comorbidity.
How it works
Grade by BP (1: 140–159/90–99; 2: 160–179/100–109; 3: ≥ 180/110; high-normal 130–139/85–89). High/very-high risk or Grade 3 → start now; moderate → weeks of lifestyle; low → 1–3 months. Target generally < 140/90 (< 130/80 if tolerated or with diabetes/CKD/coronary disease).
Key points
- High-normal BP is treated with drugs only when cardiovascular risk is high or very high, otherwise with lifestyle alone. (original synthesis · not guideline verbatim)
- Patients ≥ 80 years are individualized (around < 140/90), starting cautiously to avoid excessive lowering.
- Diabetes, CKD, or coronary disease tightens the target to < 130/80.
References
Decision support for licensed clinicians only; not a substitute for clinical judgement, diagnosis or local protocols.